Electromedical Technologies, Inc. (EMED) Stock
Electromedical Technologies, Inc. operates within the U.S.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Electromedical Technologies, Inc.
Electromedical Technologies, Inc. operates within the U.S. market, specializing in the creation and distribution of bioelectronic medical devices specifically designed for pain management. The company's primary product is WellnessPro Plus, a prescription-based bioelectronic therapy tool utilized by both individual users and healthcare professionals to mitigate various forms of discomfort, including both persistent (chronic) and sudden (acute) pain. Established in 2002, the firm is headquartered in Scottsdale, Arizona.
Electromedical Technologies, Inc. (EMED) stock trades at $0.00 with a market capitalization of $85504. The stock is valued at price-to-sales of 0.40. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, Electromedical Technologies, Inc. generates a return on equity (ROE) of 25.00% — well above the market average, a sign of a high-quality business, return on capital employed of 33.33%, an operating margin of -896.01%, a net profit margin of -182.03%.
Official website: www.electromedtech.com